4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000004
Principal Accounting Officer sold 2,272 shares at $34.39 ($78,134)
- Principal Accounting Officer acquired 6,896 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Washburn Theodore James Jr. · Principal Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,896 | 7,709 | D | ||
| 2025-02-05 | Sale : show line 2 in the form 10b5-1 | −2,272 | $34.39 | $78,134 | 5,437 | D |
| Open-market sales · 2,272 sh · avg $34.39 · $78,134 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-01 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −6,896 | 0 | D |
Loading xslF345X05/wk-form4_1738789362.xml…